RNF4 Regulates SUMOylated DNMT1 to Block Viral Mimicry From 1 New dsRNA Transcript Class
Updated
Updated · Nature.com · Jul 21
RNF4 Regulates SUMOylated DNMT1 to Block Viral Mimicry From 1 New dsRNA Transcript Class
2 articles · Updated · Nature.com · Jul 21
Summary
RNF4 emerged as a major regulator of DNMT1 catalytic function, controlling SUMOylated DNMT1 levels that preserve DNA methylation and suppress a cell-intrinsic viral mimicry response.
DNMT1 was found enriched at unmethylated CpG islands of actively transcribed genes via its CXXC domain, but selective catalytic inhibition redistributed it to partially methylated, inaccessible regions through UHRF1- and RFTS-dependent mechanisms.
7 days of sustained DNMT1 inhibition caused global hypomethylation and reactivated endogenous viral elements, including a previously uncharacterized class of double-stranded RNA mega-intergenic transcripts, or mintRNAs.
SUMOylation acted as a rheostat for DNMT1 activity, enhancing its mobility and methylation-maintenance function to repress those immunogenic transcripts rather than broadly altering coding-gene expression.
The findings sharpen the mechanism behind DNMT1-targeting epigenetic therapies by linking methylation loss to innate immune signaling while showing viral mimicry itself did not drive hypomethylation-induced cancer cell death.
Newly found 'mega-transcripts' trigger a cellular alarm. What other roles do these mysterious signals play in health and disease?
Could the body's 'viral mimicry' self-attack be turned into a new weapon to fight cancer cells?
The RNF4-DNMT1 Axis: A Breakthrough in Epigenetic Regulation and Targeted Therapy for Viral Mimicry
Overview
A major study published in July 2026 revealed a new mechanism that protects the human genome from 'viral mimicry,' where cells mistake their own genetic material for a virus. At the center of this discovery is DNMT1, an enzyme that keeps repetitive DNA sequences silent by adding methyl groups, preventing harmful double-stranded RNA and unwanted immune responses. This silencing power is boosted by SUMOylation, a modification that makes DNMT1 more effective. However, RNF4, another protein, ensures balance by targeting SUMOylated DNMT1 for degradation, tightly controlling this process and maintaining genomic stability.